Related Experiment Video
Updated: Apr 4, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control
Background:
Deregulation of synaptic plasticity and oxidative stress are reported to play a crucial role in the pathogenesis of schizophrenia. Matrix metalloproteinase-9 (MMP-9) is an extracellular protease involved in regulation of synaptic plasticity. Malondialdehyde (MDA) is a marker of lipid peroxidation which is elevated in schizophrenia. Earlier studies have reported polymorphism of MMP-9 and its association with schizophrenia. The present study was designed to assess the serum levels of MMP-9, MDA and total antioxidant status (TAS) and their association in schizophrenia.
Methods:
A total of 40 cases and 40 controls were included in the study. Serum MMP-9, MDA and TAS were estimated in all the subjects. Disease severity was assessed using Positive and Negative Syndrome Scale (PANSS).
Results:
MMP-9 and MDA were significantly increased and TAS were significantly reduced in schizophrenia cases compared to controls. MMP-9 was positively correlated with MDA (r=0.353, p=0.025) and negatively correlated with TAS (r=-0.461, p=0.003). TAS was significantly correlated with total (r=0.322, p=0.043) and negative symptom scores (r=0.336, p=0.034). Higher MMP-9 levels were associated with previous exposure to antipsychotics (p=0.032).
Conclusions:
MMP-9 and oxidative stress were increased and correlate well with each other in schizophrenia cases. Though total oxidant status showed positive association with disease severity, MMP-9 and MDA were not associated with the severity of the disease.
Insights
Schizophrenia involves increased matrix metalloproteinase-9 (MMP-9) and oxidative stress markers like malondialdehyde (MDA), with reduced total antioxidant status (TAS). These factors correlate with each other but not directly with disease severity.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Schizophrenia pathogenesis involves synaptic plasticity deregulation and oxidative stress.
- Matrix metalloproteinase-9 (MMP-9) regulates synaptic plasticity.
- Malondialdehyde (MDA) indicates lipid peroxidation and is elevated in schizophrenia.
Purpose of the Study:
- To assess serum levels of MMP-9, MDA, and total antioxidant status (TAS) in schizophrenia.
- To investigate the association between MMP-9, MDA, TAS, and schizophrenia.
Main Methods:
- Study included 40 schizophrenia cases and 40 controls.
- Serum MMP-9, MDA, and TAS were measured.
- Disease severity assessed using the Positive and Negative Syndrome Scale (PANSS).
Main Results:
- Significantly higher MMP-9 and MDA levels in cases vs. controls.
- Significantly lower TAS in cases vs. controls.
- MMP-9 positively correlated with MDA and negatively with TAS; TAS correlated with symptom scores.
Conclusions:
- MMP-9 and oxidative stress are elevated and interconnected in schizophrenia.
- While TAS correlated with disease severity, MMP-9 and MDA did not show association with symptom severity.
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...

